Efischal Pharma
FDA import alert and refusal historyBrussells, BelgiumFEI 3042278186
Recorded by FDA as EFISCHAL PHARMA
As of October 26, 2026, Efischal Pharma is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on February 19, 2026, most often for unapproved new drug (UNAPPROVED).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- L-proline (protein) · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Efischal Pharma
1 record, newest first. Each line links to the FDA page it came from.
2026
- Import refusalRefused, L-proline (protein)UNAPPROVEDEntry AEK-9318923-9Source
Refusal charges, in plain English
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Efischal Pharma
- Is Efischal Pharma on an FDA import alert?
- No listing for Efischal Pharma appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Belgium page.
- Has FDA refused shipments from Efischal Pharma?
- Yes. FDA refused 1 shipment line from Efischal Pharma on February 19, 2026. The most recent, on February 19, 2026, was l-proline (protein), charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Efischal Pharma's shipments?
- The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
- What is Efischal Pharma's FEI number?
- Efischal Pharma's FDA Establishment Identifier (FEI) is 3042278186.
Buying from Efischal Pharma?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.